Balamurali Ambati
Research Professor · Oregon Health & Science University
Credentials: · · · · · · · ·
History
- 1996–1999
- 1995–1996
Preliminary or Transitional Year
Research
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Review · Survey of Ophthalmology · 2003 · 750 citations
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Nature · 2008 · 740 citations
Corneal avascularity is due to soluble VEGF receptor-1
Nature · 2006 · First of 37 authors · 563 citations

40 papers · 7 as a resident
- JB
14 papers

10 papers · 3 as a resident
- BF
9 papers · 1 as a resident
- MK
9 papers · 6 as a resident
- AA
7 papers

7 papers · 4 as a resident
- JC
7 papers · 6 as a resident
Grants
- 2008–2023
National Eye Institute · R01
Contact PI · $5.2M · University of Oregon
- 2016–2020
Comp-ang1: Vascular Normalization and Neuroprotection for Diabetic Retinopathy
National Eye Institute · R01
Contact PI · $1.3M · Loma Linda University
- 2007–2018
Intraceptor Interference of VEGF in Ocular Angiogenesis
National Eye Institute · R01
Contact PI · $3.6M · Utah State Higher Education System--University of Utah
- 2009–2017
Targeted Morpholino Interference of VEGF Pathways in Ocular Angiogenesis
Department of Veterans Affairs · I01
Contact PI · Va Salt Lake City Healthcare System
Clinical trials
- 2019–2030
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Principal investigator · Recruiting · Phase 1
Pacific Clear Vision Institute
- 2014–2016
Principal investigator · Withdrawn · Phase 1
University of Utah
- 2013–2015
Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
Principal investigator · Terminated · Phase 1
Balamurali Ambati
- 2019–2020
Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients
Study director · Completed · Phase 1, Phase 2
iVeena Delivery Systems, Inc.